This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "Clinical Quality Information WGM May 2018, Cologne, Germany - Minutes"

From HL7Wiki
Jump to navigation Jump to search
 
(14 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
[http://wiki.hl7.org/index.php?title=Clinical_Quality_Information Back to CQI Wiki Page]<br><br>
 
[http://wiki.hl7.org/index.php?title=Clinical_Quality_Information Back to CQI Wiki Page]<br><br>
 
<br>
 
<br>
'''''D R A F T - T E M P L A T E for CQI WGM Minutes - Cologne Germany - May 2018'''''
+
'''''CQI WGM Minutes - Cologne Germany - May 2018'''''
 
__FORCETOC__
 
__FORCETOC__
==Attendance - '''''DRAFT ATTENDANCE LOG''''' for the full week May 14-18, 2018==
+
=='''''ATTENDANCE LOG''''' for the full week May 14-18, 2018 ==
 +
NOTE - attendance is recorded for sessions during which the CQI WG met alone or hosted other Workgroups. Attendance during sessions during which other Workgroups hosted CQI is recorded by the hosting Workgroup
 
===CQI May 2018 Workgroup Meeting Attendance===
 
===CQI May 2018 Workgroup Meeting Attendance===
 
<p style="font-size:7px">
 
<p style="font-size:7px">
Line 54: Line 55:
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Ben Ghahhari</font>
 
| row2cell2 | <font size="1">CMS</font>
 
| row2cell3 | <font size="1">benjamin.ghahhari@cms.hhs.gov</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Ben Hamlin</font>
 
| row2cell2 | <font size="1">NCQA</font>
 
| row2cell3 | <font size="1">hamlin@ncqa.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 113: Line 76:
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| row2cell4 | <font size="1">.x</font>
+
| row2cell4 | <font size="1">.X</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
Line 171: Line 134:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Claudia Hall</font>
 
| row2cell2 | <font size="1">Mathematica</font>
 
| row2cell3 | <font size="1">chall@mathematicampr.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Chana West</font>
 
| row2cell2 | <font size="1">ESAC Inc</font>
 
| row2cell3 | <font size="1">chana.west@esacinc.com </font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
Line 225: Line 150:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Dan Donahue</font>
 
| row2cell2 | <font size="1">ESAC</font>
 
| row2cell3 | <font size="1">dan.donahue@esacinc.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 263: Line 169:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#f0f0f0;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Dan Morford</font>
 
| row2cell2 | <font size="1">VZ/VA</font>
 
| row2cell3 | <font size="1">Dan.morford@bookzurman.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 458: Line 345:
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Hafsa Subhan
 
| row2cell2 | <font size="1">The Joint Commission
 
| row2cell3 | <font size="1">hsubhan@jointcommission.org
 
| row2cell4 | <font size="1">.
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 512: Line 380:
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Jamie Lehner</font>
 
| row2cell2 | <font size="1">PCPI</font>
 
| row2cell3 | <font size="1">jamie.lehner@thepcpi.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 606: Line 455:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;" |<font size="1"> X</font>
+
| align="center" style="background:#72777d;" |<font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 624: Line 473:
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
| row2cell4 | <font size="1">.</font>
+
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
Line 701: Line 550:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
| row2cell4 | <font size="1">.</font>
+
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Linda Michaelsen</font>
 
| row2cell2 | <font size="1">Optum</font>
 
| row2cell3 | <font size="1">linda.michaelsen@optum.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
Line 736: Line 566:
 
| row2cell3 | <font size="1">landerson@jointcommission.org</font>
 
| row2cell3 | <font size="1">landerson@jointcommission.org</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;"| <font size="1">X</font>
+
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
Line 744: Line 574:
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
+
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 781: Line 611:
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Matthew Tiller</font>
 
| row2cell2 | <font size="1">ESAC</font>
 
| row2cell3 | <font size="1">matthew.tiller@esacinc.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Mitra Biglari</font>
 
| row2cell2 | <font size="1">The Joint Commission</font>
 
| row2cell3 | <font size="1">mbiglari@jointcommission.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Pamela Mahan-Rudolph</font>
 
| row2cell2 | <font size="1">Memorial Hermann</font>
 
| row2cell3 | <font size="1">pamela.mahanrudolph@memorialhermann</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
Line 1,017: Line 790:
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
|-
| row2cell1 | <font size="1">Steve Bratt</font>
+
| row2cell1 | <font size="1">Stefan Lang</font>
| row2cell2 | <font size="1">MITRE</font>
+
| row2cell2 | <font size="1">HITC</font>
| row2cell3 | <font size="1">sbratt@mitre.org</font>
+
| row2cell3 | <font size="1">Stefan.lang@lang-HITC.de</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 1,027: Line 800:
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
| row2cell4 | <font size="1">X</font>
 
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
+
| row2cell4 | <font size="1">.</font>
 +
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 1,036: Line 809:
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
|-
| row2cell1 | <font size="1">Susan Matney</font>
+
| row2cell1 | <font size="1">Steve Bratt</font>
| row2cell2 | <font size="1">Intermountain Healthcare</font>
+
| row2cell2 | <font size="1">MITRE</font>
| row2cell3 | <font size="1">susan.matney@imail.com</font>
+
| row2cell3 | <font size="1">sbratt@mitre.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 1,055: Line 828:
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
|-
| row2cell1 | <font size="1">Sweta Ladwa</font>
+
| row2cell1 | <font size="1">Susan Matney</font>
| row2cell2 | <font size="1">ESAC inc</font>
+
| row2cell2 | <font size="1">Intermountain Healthcare</font>
| row2cell3 | <font size="1">sweta.ladwa@esacinc.com </font>
+
| row2cell3 | <font size="1">susan.matney@imail.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 1,065: Line 838:
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
| row2cell4 | <font size="1">.</font>
+
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
Line 1,135: Line 908:
 
| row2cell3 | <font size="1">walter.g.suarez@kp.org </font>
 
| row2cell3 | <font size="1">walter.g.suarez@kp.org </font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
| align="center" style="background:#72777d;"| <font size="1">X</font>
+
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
Line 1,144: Line 917:
 
| row2cell4 | <font size="1">X</font>
 
| row2cell4 | <font size="1">X</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">X</font>
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Yan Heras</font>
 
| row2cell2 | <font size="1">Optimum Health</font>
 
| row2cell3 | <font size="1">yanheras@gmail.com</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Yanyan Hu</font>
 
| row2cell2 | <font size="1">The Joint Commission</font>
 
| row2cell3 | <font size="1">yhu@jointcommission.org</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"|<font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
|-
 
| row2cell1 | <font size="1">Zach May</font>
 
| row2cell2 | <font size="1">ESAC Inc</font>
 
| row2cell3 | <font size="1">zachary.may@esacinc.com </font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#72777d;" |<font size="1"> .</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| row2cell4 | <font size="1">.</font>
 
| align="center" style="background:#f0f0f0;"| <font size="1">.</font>
 
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
 
| align="center" style="background:#72777d;"| <font size="1">.</font>
Line 1,435: Line 1,151:
  
 
PSS on DaVinci Project -  
 
PSS on DaVinci Project -  
* Revised project proposal was presented (Version 1.3).  Changes made were consistent with those discussed in Q2.
+
* Revised project proposal was presented (Version 1.3) [http://wiki.hl7.org/index.php?title=File:FHIR%2BImplementation%2BGuide%2Bfor%2BExchange%2Bof_-data%2Bfor%2BQuality%2BMeasures%2B20180516_V1.5.docx Revised PSS for FHIR IG for Exchange of Data for Quality Measures].  Changes made were consistent with those discussed in Q2.
 
* A '''''motion''''' to approve the PSS was moved by Bryn; Seconded by Walter; 17, 0, 2
 
* A '''''motion''''' to approve the PSS was moved by Bryn; Seconded by Walter; 17, 0, 2
  
Line 1,451: Line 1,167:
  
 
==Thursday, May 17, 2018 CQI WGM Minutes==
 
==Thursday, May 17, 2018 CQI WGM Minutes==
'''''Q1'''''
+
'''''No Meeting'''''
* No Planned Meeting - Notes from PC meeting
 
* Agenda Topics
 
**
 
* Chair - n/a, Scribe - n/a
 
* Discussion:
 
** <br>
 
** <br>
 
<br>
 
<br>
 

Latest revision as of 16:58, 5 September 2018

Back to CQI Agenda and Minutes Page

Back to CQI Wiki Page


CQI WGM Minutes - Cologne Germany - May 2018

ATTENDANCE LOG for the full week May 14-18, 2018

NOTE - attendance is recorded for sessions during which the CQI WG met alone or hosted other Workgroups. Attendance during sessions during which other Workgroups hosted CQI is recorded by the hosting Workgroup

CQI May 2018 Workgroup Meeting Attendance

Attendee Attendee's Organization Attendee's email Mon
14 May Q2
Mon
14 May Q3
Mon
14 May Q4
Tue
15 May Q1
Tue
15 May Q2
Tue
15 May Q3
Tue
15 May Q4
Wed
16 May Q1
Wed
16 May Q2
Wed
16 May Q3
Wed
16 May Q4
Thu
17 May Q1
Thu
17 May Q2
Thu
17 May Q3
Thu
17 May Q4
Athla Farkas Canada Health Infoway afarkas@infoway.ca . . . . . . . X . . . . . . .
Bas van der Henvel Philips bas.van.der.henvel@philips.com X . . X X . . . . . . . . . .
Brian Alper EBSCO balper@ebsco.com . . . . . . X .X . . . . . . .
Bryn Rhodes ESAC bryn@databaseconsultinggroup.com X . . . X . X X X X . . . . .
Cesar Moreno HL7 Argentina cmoreno2003@gmail.com . . X X X . X X X X . . . . .
Claude Nanjo University of Utah claude.nanjo@utah.edu . . . . . . . X . . . . . . .
Craig Parker Intermountain Health Care craig.parker@imail.com . . . . X . . . . . . . . . .
DoYoun Lee Hegel/font> . hegel/dy@gmail.com . . . . X . . . . . . . . . .
Daryl Chertroff HLN Consulting daryl@hln.com . . . . X . . . . . . . . . .
Dave Carson VHA dcarlson@xmlmodeling.com . . . . X . . . . . . . . . .
Diana Ovelgoenne Siemens dianal.ovelgoenne@siemens-healthineers.com . . . . . . . . . X . . . . .
Doug Martin Regenstrief douglas.martin.md@gmail.com . . . . X . . . . . . . . . .
Floyd Eisenberg iParsimony, LLC FEisenberg@iParsimony.com X . X X X . X X X X . . . . .
Franck Gener Phast Services franck.gener@phast.fr . . . . . . X . . . . . . . .
Gay Dolin IMO gdolin@imoonline.com . . . . X . . . . . . . . . .
Gustavo Carolo HL7 Argentina gcarolo@garrahan.gov.ar . . X X X . X X X X . . . . .
Humberto Mamdirola HL7 Argentina hmandirola@gmail.com . . X X X . X X X X . . . . .
Isaac Vetter EPIC Isaac@epic.com . . . . X . . . . . . . . . .
Isabella Gibaud Phast Services Isabella.gibaud@phast.fr . . . . . . X . . . . . . . .
Jerry Goodnough Cognitive Medical Systems JGoodnough@cogmedsys.com . . . . X . . . . . . . . . .
Joep van Berhel Philips joep.van.berhel@philips.com X . . . . . . X . . . . . . .
John Loonsk CGI EBD / APITC john.loonsk@cgifederal.com . . . . . . X X . . . . . . .
Joshua Mandel Children's Harvard Joshua.mandel@childrens.harvard.edu . . . . X . . . . . . . . . .
Jukhani Munish NHSD munishjukhani@nhs.net . . . X . . . . . . . . . . .
Juliet Rubini Mathematica jrubini@mathematicampr.com . . . . . . X X X X . . . . .
Ken Kawamoto University of Utah kensaku.kawamoto@utah.edu . . . . X . . X X X . . . . .
Kevin Olbrich McKesson Kevin.olbrich@mckesson.com . . . . X . . X . . . . . . .
Kevin Shekleton Cerner kevin.shekleton@gmail.com . . . . X . . . . . . . . . .
Lisa Anderson The Joint Commission landerson@jointcommission.org X . X X X . X X X . . . . . .
Lorraine Constable . lorraine@constable.ca . . . . . . . X . . . . . . .
Magbool Hussain Sejong University, Korea magbool110@gmail.com . . . . X . . X . . . . . . .
Patty Craig The Joint Commission pcraig@jointcommission.org X . X X X . . . X X . . . . .
Paul Denning MITRE pauld@mitre.org . . . . X . X X X X . . . . .
Richard Esmond PenRad drichard@penrad.com . . . . . . . X . . . . . . .
Rick Geimer Lantana rick.geimer@lantanagroup.com . . . . X . . . . . . . . . .
Robert Dieterle Enable Care rdieterle@enablecare.us . . . . . . . . X X . . . . .
Robert Jenders UCLA jenders@ucla.edu . . . . X . . X X X . . . . .
Sam Nicolary HLN Consulting sdn@hln.com . . . . X . . . . . . . . . .
Stan Huff Intermountain Healthcare stan.huff@imail.org . . . . . . . X . X . . . . .
Stan Rankins Telligen SRankins@telligen.com . . X X X . X X X X . . . . .
Stefan Lang HITC Stefan.lang@lang-HITC.de . . . . . . . . . X . . . . .
Steve Bratt MITRE sbratt@mitre.org . . . . . . . X . . . . . . .
Susan Matney Intermountain Healthcare susan.matney@imail.com . . . . . . . X . . . . . . .
Thomson Kuhn ACP tkuhn@acponline.org . . . X X . . X . . . . . . .
Vassil Paytchev Epic vassil@epic.com . . . . . . . . X . . . . . .
Vincent McCauley Telstrahealth vincem@bigpond.com . . . . . . . X . . . . . . .
Walter Suarez Kaiser walter.g.suarez@kp.org X . X X X . . X X X . . . . .

Monday, May 14, 2018 CQI WGM Minutes

Q1

  • No Meeting - HL7 Plenary Session

Q2

  • Agenda Topics
    • CQI Business Meeting
  • Chair - Walter Suarez; Scribe - Floyd Eisenberg
  • Discussion:
    • Walter reviewed the scope of CQI WG
    • Bryn volunteered to act as interim co-chair to support meetings through the week
      • Floyd moved to appoint Bryn Rhodes, Patty seconded, Vote - 10 approve, 0 abstain, 0 opposed
    • Walter reviewed the agenda for the week - Floyd updated the agenda as we discussed during the call
    • Floyd reviewed the new steering committee structure

Q3

  • Orders and Observations (OO) hosting CQI
  • Agenda Topics
    • Use of Observation Resources - Design Patterns
    • Order Set and Plan Definitions
    • Catalog resource definitions
  • Chairs: Lorraine - See OO agenda for attendance

Discussion

  • Alerting and Alarms
  • Order Catalogue
  • FHIR Tracker items
    • FHIR Tracker Items
    • 15942 – NutritionOrder – consistent modeling of .status Vs .intent with the rest of FHIR – modeling inconsistent with other FHIR resource modeling. Loraine was able to find the modeling now does include the intent metadata element in the STU 4 ballot. It has been harmonized.
      • Withdrawn by commenter
    • 15943 – NutritionOrder – NutritionOrder modeling - differences with ServiceRequest, MedicationRequest . The use case is the ability or order a specific dietary item. Nutrition order is modeled as the ability to order enteral diet, a nutritional supplement, a parenteral diet, etc. (E.g., oral diet - with types that include multiple diet type) - The NutritionOrder is a work in progress - needs to address a specific nutrient. The idea is to describe a nutrient modifier but the question is how to address "notDoneReason" and also to define a specific nutrient at the exclusion of all others.
      • There is always one diet for a patient active at any time, but supplements are different and might be addressed later on. See tracker item: 17164
      • Motion to break into 3 tracker items to follow and resolve each independently: Create tracker to harmonize the NutritionOrder to match the Request Pattern and handle NotDoneReason - see tracker item: 17166
      • Discuss how to handle boundaries and modeling when adding a supplement to an existing diet - do you entirely replace, or add? See tracker item: 17167
      • Motion by Ken McCaslin, second by Floyd Eisenberg - 26 approved, 0 opposed, 3 abstain
    • 15945 – SupplyRequest modeling (general) and related to blood products (SupplyDelivery, SupplyRequest, and BiologicallyDerivedProducts). This subject is currently under development. Supply request is not the correct resource. This is on Wednesday Q3 Patient care agenda this week.
      • Motion: Rob Hausam, Second Richard Esmond: Balloters will connect with project team (see link in FHIR traker)to assure use cases are covered in that material. Vote - 29-0-0
    • Immunization - the current modeling provides documentation details about immunization administration or a forecast (immunization recommendation) but not an order - referred to Public Health workgroup for follow up.
  • Order Catalogue
    • Claude Nanjo discussed work on Order Catalogue - joined forces with Francios Macary - to define the core FHIR resource to represent the catalog for order entry. Proposal - use composition resource and introduce in a future profile a notion of a catalogue entry - to wrap an item as part of a catalog. This discussion is consistent with managing order sets. The connectathon created a catalog and sought to query for a catalog and elements. The Catalogue profile - needs to capture the business content used in the V2 catalogue for lab which is the most complex in V2. Conceptually, the FHIR resources need to capture identified, contributor, version, status publisher, copyright, title, Catalogue entry (identifier, contributor serviceProvider, orderable, version, status status Date Title, ChargeInforation, SpecimenDefinition, SpecimentToLab, Container, Handling, Lab service, ObservationSpecification, Units. Lorraine showed V2 modeling - some of the details are included in the notes here. ---- Richard Esmond suggested there is parallel with Imaging Requests - work with registries to get LOINC identifiers defined - should join with RadLAC - coordinate with II (Imaging Integration). Needs to also address Appropriate Use Criteria and CDS Hooks - to perform, needs to trace all the way along if there is a recommendation to process and order - and track if the order occurred and how it was handled. This discussion addresses the catalogue of what can be ordered.
    • Other material addresses order management - fulfillment has not been sufficiently addressed.
    • Claude showed examples of the order catalogue content.Link to Order Catalog

Q4

  • Agenda Topics
    • CQI Meeting - Planning for September
  • Chairs: Walter Suarez, Scribe: Floyd Eisenberg

Discussion:

  • Decision Making Process - due to some edits to the default DMP, the CQI WG reviewed our individual WG addendum and believes that the addendum is still required.

Floyd Eisenberg moved to re-affirm our DMP addendum, Patty Craig seconded - Vote 6-0-0

  • Planning for September
    • 30-day Medication Reconciliation PSS under consideration. Plan is to review the PSS Wednesday Q2 and consider an STU ballot for September to address an implementation guide to manage publication of data by the EHR and subscription by a data analytic engine for the data, then aggregation and analysis for reporting to a reporting agency. The STU will use 30-day med reconciliation as the example.
    • Evidence-based Medicine (EBM) on FHIR (CDS primary) - approved by CDS and CQI - current plan is to ballot for comment only in September. The project facilitator (Brian Alper) will review with Biological Regulated Research (BRR) for potential co-sponsorship (perhaps during this quarter) and then bring modified PSS to CDS and CQI on Wednesday Q2 for review and possible re-vote if needed, then submit to FHIR Management Group and Clinical Domain for approval.
    • FHIR Quality for QI Core to ballot in September (Project 1125) and PSS is up-to-date. The work requires publication of QI Core / QUICK STU 3 based on the completed ballot reconciliation from January 2018. Then we need to update to FHIR STU 4 and US FHIR Core STU 4 for the September ballot.
    • No known need for new ballots for CQL-based HQMF (CQI managed) or CQL (CDS managed) but both PSS' are current and active


Tuesday, May 15, 2018 CQI WGM Minutes

Q1
Agenda Topics

  • CQI Meeting
  • Chair - Floyd Eisenberg, Scribe - Walter Suarez
  • Discussion:

From the agenda, we had already completed the project planning and PSS review for September ballots, and had coordinated ballot reconciliation for the week. We focused on the following items:

  1. Floyd and Walter provided a review of the discussion and actions taken during the Steering Division meeting. This was the first meeting under the new Domain Expert structure. CQI is now part of the new Clinical Steering Division (formerly Domain Experts).
  2. CQI has received a request from Arden Syntax to consider supporting their request to move from Infrastructure SD to Clinical SD (as they seem to work closely with CDS and, in some cases with CQI. The feeling among the CQI group was that Arden Syntax seems to be much more of an Infrastructure component of HL7 work, rather than a Clinical working group. Thus, we are deciding to not get involved in the request from Arden Syntax.
  3. During the Steering Division, we were informed of the need to review and update/approve the WG Mission and Charter. We discussed and updated the Mission and Charter - last updated in 2017. Several changes were made, mainly eliminating the detail listing of projects, which seem to be more appropriately moved to our 3-year workplan. The plan is to submit the revised M&C to the CQI List, and review it with the WG during our upcoming calls, and get it completed and approved in the next few weeks, well before the September deadline.
  4. The WG discussed a new issue - how to handle of transition from ED to Inpatient status, when there is an 'observation' period in between. The question is where would that be captured in the current system. We understand that in FHIR this will be addressed. We will do some research and find out with some other people think, and come back to this issue during one of our calls.
  5. We reviewed our next meetings.



Q2
CQI hosts CDS and FHIR
Agenda Topics

  • CDS Hooks 1.0 ballot reconciliation
  • FHIR Clinical Reasoning ballot reconciliation (if time)
  • Chair - Floyd Eisenberg; Scribe - Walter Suarez
  • Discussion:
    • CDS Hooks 1.0 Ballot Reconciliation:
    • Main topics: Negative comments about security; comment about analytics; comment about response
  1. Item 106: "prefetch" - recommend specifying that prefetch should only include data allowed within scopes. ## Discussion: Proposal is that this is not persuasive; in the document it is described
    1. Moved as Not Persuasive: Josh; second: Bryn; 23 for; 3 abstentions; 0 oppose
  2. Item 120: Current SMART scope specification seems too broad to meet HIPAA for minimum necessary.
    1. Discussion: this will be brought up to the larger overarching FHIR group to discuss implications of HIPAA.
    2. Moved as Persuasive with Mod. moved by Ken; second by Bryn; 25; 0 against; 1 abstain
  3. Item 150: Issue is that "Client_id" is included in the document, but no reference or description is given.
    1. Discussion: in the Jason Web Token (JWT) there is a field "sub" described as "Client_id of the EHR". However, nowhere there is an explanation of what Client_ID is. Our interpretation is that this is the OAuth2.0 identified. However, it is not described anywhere. Recommendation: Persuasive with Mod; recommending to remove the Client_id. We acknowledge that by removing it we would be not in compliance with JWT Profile for OAuth Authentication.
    2. Moved as Persuasive with Mod; by Kevin; second by Josh. 26; 0; 0.
  4. Item 115: Issue is about Analytic Endpoint. In general, this feature has not been widely implemented. Comment is that the Analytics Endpoint instead of being and endpoint, should be describe more generically. It should be provided as a part of service metadata. The CDS service should advertise the URL so the EHR knows where to go.
    1. Discussion: We recommend Persuasive with Mod, and should remove what little there is on Analytics from the specification, and focus on producing a stronger specification that allows more advanced use cases, and do a testing during an upcoming connectathon.
    2. Moved as Persuasive with Mod by Isaac; second by Bryn. 26; 0; 0.
  5. Item 127: Issue is about the CDS services respond to the EHR. CDS response can contain a suggestion. FHIR Clinical Reasoning has a new resource called Detectedissue. So Cards should also support this resource.
    1. Discussion: We like the generic notion of allowing Detectedissue to be included as a "suggestion" even though it is not an order. Recommend Persuasive with Mod; the desired functionality is persuasive and this is something we will consider for future use, including exploring other FHIR resources (in addition to the proposed Detectedissue), other card types, other interaction methods, etc.
    2. Moved Bryn; second Isaac; 25; 0; 1
  6. Item 134: On the CDS response there can be many cards. There is information about how to prioritize the cards (Info, Warning, Hard Stop). This value set is mixing urgency indicators with user experience.
    1. Discussion: we recommend that Info and Warning be considered common priorities; and rename Hard Stop to 'critical' priority.
    2. Recommendation: Persuasive with Mod. Rename Hard Stop to Critical. Moved Josh; second Bryn; 25; 0; 0
  7. Item 26: About Prefetch Token. When a CDS service defines a prefeth, the way to represent that is with various elements, including patient ID. It uses certain characters in the string, like french brackets. This is a prefetch token. They must exist at the context level/root level of the entire element. Comment is why the prefetch token must be limited to the content element? Spec is not clear that the prefetch token is limited to the content element.
    1. Discussion: The prefetch token must be limited to the content element, except when is referring to a user in context. So, if we move user to in context that would address the issue. Recommendation: Persuasive with Mod. Move the CDS Service request "User" field to the Hook Context and document that each hook author shall include the "user" field to the hook contect field if it is appropriate to the hook. We acknowledge this breaking change but feel now is the time to do this. In doing this, we will address the ballot comment (by clarifying that prefetch templates relat to context parameters) and possibly allow for non-user initiated CDS hooks calls.
    2. Moved Josh; second Bryn; Discussion: As we define new hooks, remind people that they have to put it there. All hooks need it. All have user in context. We can add language that the document specify that this is needed. Modification was done and accepted to add that document in the spec that each hook author shall include the "user" field.
    3. Vote: 24; 0; 0


Q3

  • CDS hosts CQI and FHIR
  • Agenda Topics
    • CDS Hooks ballot reconciliation (continued from Q2)
  • Chairs: See CDS Minutes and attendance - CDS Chairs present - Ken Kawamoto, Robert Jenders, CQI Co-chairs - Floyd Eisenberg, Patty Craig (telephone)
  • Discussion - items reviewed listed below - see ballot reconciliation spreadsheet for details
    • Ballot item # 83
    • Ballot item # 99
    • Ballot item # 160 (Hooks grouping)
    • Ballot item # 130 (Hooks grouping)
    • Ballot item # 132 (Hooks grouping)
    • Ballot item # 111
    • Ballot item # 121 (Discovery endpoint grouping)
    • Ballot item # 124 (FHIR grouping)


Q4

  • Agenda Topics
    • CQI Meeting - CQL-based HQMF Ballot Reconciliation
  • Chairs: Bryn Rhodes (Interim Chair), Scribe: Floyd Eisenberg
  • Discussion:
    • CQL -based HQMF - 152 comments - 124 unique (28 were duplicates)
    • The main question on the ballot addressed how to represent the composite - include the HQMFs (option 2), or reference the HQMFs of the component measures (reference the HQMFs)
      • Vote was 4 for option 1, 1 vote for option 2, 1 abstention in the ballot comments
      • There are 23 composite measure support comments on the ballot. Constraints on HQMF currently require change in conformance to the normative standard to accommodate option 1 (and thus more work in the CQL-based HQMF conformance requirements). Option 2 allow use of the HQMF "as is" and provides all information for implementers to calculate. However, Option 2 would need to be constrained to individual-level composites only, not population-based measures. Individual composites combines the component measures but calculates for the individual. Population-based component measures calculate the composite on the results of the component scores - this approach requires population-context expression.
      • Discussion did not lead to a decision due to insufficient representatives to address the issue. Some are leaning to Option 2 - it can be delivered with current tooling but does not have to be fully incorporated in the Measure Authoring Tool. Minimum viable composite measure would have identification of the component measures in the composite measure document - the tooling would need to support the set of component measures whether or not the CQL is incorporated.
        • Step 1 - the implementer would need to find all the component measures - the MAT needs to reference the component measures
        • Step 2 - The tool could include the CQL from the component measures automatically, or the measure developer would need to re-build each component measure expressions within the composite measure.
        • There is no decision today - for review at a subsequent meeting
    • All other comments are persuasive and can be most likely managed with a block vote
      • 23 on composite measure support
      • 11 on conformance statements
      • 5 on continuous variable measures - additional clarification on the specifications and calculations
      • 19 errata
      • 6 comments on terminology - some questions referencing invalid OIDs and some on direct reference code clarifying documentation (and whether version should be specified in direct reference codes)
      • 7 comments on updating to QDM 5.4
      • 22 comments on nomenclature (e.g., eCQM not eMeasure)
      • 13 comments on updating references
      • 11 website comments


Wednesday, May 16, 2018 CQI WGM Minutes

Q1
CQI Hosts CIMI and CDS

  • Topics:
    • Clinical activities and needs for standards for CDS and measurement: Pulmonary Embolus (PE) Risk Assessment SMART on FHIR app (Susan Matney)
    • CDS KNART Project review (15 minutes)
    • CDS Hooks 1.0 Ballot reconciliation (tentative)
    • QI Core content review with CIMI and future direction
  • Chair - Floyd Eisenberg, Scribe - Walter Suarez
  • Discussion:


CDS KNART:

  • Claude provided an update on KNART (slides)
  • Since last meeting: Trial XML compositional schema; errata collection; preliminary abstract; preliminary event mapping and propagation model; initial relationship between composite and components execution defined; KAS and FHIR comparison and mapping started
  • Next steps: formal conceptual model development; abstract definition of various lifecycles (governance, execution, event propagation); schema update and integration; formalization, model creation, and write uoo
  • Sharing information about the best practices, what work, what didn't, from implementation sites would be helpful
  • Information about the KNART calls on Thursdays will be submitted by Claude, for the minutes


PULMONARY EMBOLISM Presentation

  • Susan presented on the PE Risk Assessment SMART on FHIR app
  • The application uses a lot of calculations and algorithms, and kicks out an alert message. A list of alert messages is included in the excel file.
  • Table presents the Alert Message, Order, Test, Result, Recommendation Impression
  • Suggestion is to bring up the way to present CDS outputs to the CDS Hooks, and focus here on building the logic.
  • There was discussion about the flow of the process (graphic from Bryn, from the CLinical QUality Framework - Opioid-CDS - http://build.fhir.org/ig/cqframework/opioid-cds/integration-documentation.html


CDS HOOKS Reconciliation

  • All that was required to be completed this week was completed yesterday. Everything else will be via block vote


EMS QUality Measure Project

  • Lori Fourquet presented an overview of a new EMS Quality Measure initiative, to develop a profile to fulfill the need for EMS measurement. A link to the project, which is about to go out for comment, will be shared with the group


DEALING WITH DATA MODEL IN QI CORE

  • What we have done is take the original QI Core, balloted in January, 2018, and map QDM directly to QI Core
  • Every data element in QI Core must map back to a data element in QDM
  • For example, QDM has an encounter order (which has three contexts); QI Core has a corresponding reference element
  • Next step: want to have a discussion in Q4 with CIMI to look at how to converge this mapping with CIMI


Q2

  • CQI hosts CDS
  • Agenda Topics (proposed):
    • CQL ballot (full ballot ends June 6, but review changes and discussion of possible query change)
    • Proposal for Evidence-based Medicine (EBM) on FHIR
    • PSS 30-day Medication Reconciliation Review (Da Vinci) - Bob Dieterle
  • Chair - Walter Suarez; Scribe - Floyd Eisenberg; Scribe
  • Discussion:
    • Evidence-based Medicine on FHIR - Brian Alper - Agenda for EBMonFHIR project:
      • Project Definition – review and discussion of project need and project scope, minor changes (10 minutes)
      • Project approach and logistics – layout the components of project initiation (20 minutes)
      • Draft framework – the actual details of the project (0 minutes, but we can start if we get through the agenda more quickly than expected) EBM on FHIR Introduction from CDS WG call April 25 2018
      • Brian presented the updated PSS (updated from the previously approved PSS based on discussions with Graham Grieve and others): Project Scope Statement - EBM on FHIR - the update includes drafting and recruiting for Sep 29 connectathon and (urgent) the need to draft what connectathon structures would be needed in the next few weeks. BRR also suggested search terms as a shareable resource, and interest for domain model for inclusion and exclusion criteria for research recruitment/enrollment. Changes include a change of vocabulary facilitator (Russell Hamm) and deliverables and target dates (start with connectathon work September 2018 and January 2018, then ballot as STU in May 2019, second ballot September 2019.
      • The CDS and CQI Workgroups agreed that a revote on the PSS would be helpful to confirm approval of CDS as the sponsor and CQI as a co-sponsor. Motion to approve the PSS (CDS sponsor and CQI co-sponsor) - Floyd Eisenberg, Ken Kawamoto second. Bryn suggested a friendly amendment to include reference to the communities that will participate in the connectathon to assure there is a participating community. The PSS lists immplementers - EBSCO Health, HarmoniQ, Duodecim Medical Publications Ltd, and MAGIC - the first two have commitments to participate. The PSS needs to indicate how it will build the community - will add that the project will build an EBM-onFHIR community to coordinate input and dissemination across the many communities described in the PSS. Also added - This project may create new resources if it identifies gaps. Floyd and Ken accept the amendment to the motion. Vote 18 approve, 0 opposed, 3 abstain
    • Brian presented EBM on FHIR Project Initiation Tasks. Bryn suggested creation of a discussion stream on Zulip. He will work with Graham, Bryn and others to work through the communication and participation process.
    • PSS for 30 Day Medication Reconciliation project - request for CQI - Bob Dieterle. The project comes from DaVinci - a payer-provider-HIT vendor sponsored group to develop implementation guides for value-based use cases and will work through HL7 WGs appropriate to individual projects. This PSS is the first project defined by DaVinci - FHIR Implementation Guide for Data Exchange for Quality Measurements with Medication Reconciliation Post-Discharge as a Use Case. The initial use case is data exchange for a measure, the next step is the definition of the flow required to perform reconciliation. CQI is requested as the primary sponsor. Still needs a publishing and vocabulary facilitator.
      • Discussion suggested that the framework should be addressed at the initiation of the PSS and the example follow that framework. The PSS should describe a more generic framework to determine the required plumbing, then discuss how the example will show the value of the framework. The recommendation also suggested that the title not include the example, but using more general quality measurement as the need for the PSS. Bob will update the PSS for review by the workgroup for decision for Q4.


Q3
CQI Hosts CDS

  • Agenda Topics
  • Presentation from non-US clinical sites Argentina) regarding current activities and needs for standards for CDS and measurement
  • FHIR Clinical Reasoning module review
  • CQL-based HQMF Ballot Reconciliation
  • PSS 30-day MedRec - continue discussion
  • Chairs: Floyd Eisenberg; Walter Suarez
  • Discussion

PRESENTATION FROM ARGENTINA Slide deck

  • Overview of Argentina's health system (three parts: Union Worker Social Security - 53%; Public System - 37%; Private - 10%
  • Have used CDS for Clinical Laboratory, and also tried to use Arden Syntax, but without much success due to lack of technical support for Arden Syntax
  • Similarly, used CDS in Nutrition Alerts and other areas to build alerts.
  • The country does not have a national or regional quality reporting system that collects quality measures centrally.

CLINICAL REASONING Review

  • Ballot reconciliation will be done after the WG Meeting

CQL-BASED HQMF Ballot

  • Bryn led a discussion about Composite Measures
  • Recommendation is to do Option 2 (include CQL) for the Composite Calculation; and explicitly document how you build those calculations; and that we don't support component-linear weighted
  • Concern is not including component-linear for future considerations. In that case the idea would be to bring it back to discuss how the model would work and the IG could address it
  • If we were to say use FHIR Clinical Reasoning measure, could we address this? Yes, it would be more easily addressed.
  • At some point in the future, when measure move from FHIR Clinical Reasoning, they can be addressed down the road.
  • Bryn moved to approve strawman as preferred approach. Lenel second. 14, 0, 3

PSS on DaVinci Project -


Q4

  • CDS hosts CQI and CIMI
  • Agenda Topics
  • See CDS minutes and agenda for details and attendance
  • QI Core content review with CIMI and future direction
  • CIMI for Quality
  • Chairs: See CDS Minutes
  • Discussion:
  • See CDS Minutes


Thursday, May 17, 2018 CQI WGM Minutes

No Meeting